Nanobiotix SA
PAR:NANO
Nanobiotix SA
PAR:NANO
Price:
25.8
EUR
-5.84%
Market Closed
Market Cap:
€1.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nanobiotix SA
PAR:NANO
|
FR |
|
Saferoads Holdings Ltd
ASX:SRH
|
AU |
|
Sim Leisure Group Ltd
SGX:URR
|
MY |
|
Liberty Media Corp
NASDAQ:LSXMA
|
US |
|
Stemmer Imaging AG
XETRA:S9I
|
DE |
Balance Sheet
Balance Sheet Decomposition
Nanobiotix SA
Nanobiotix SA
Balance Sheet Decomposition is not available for
Nanobiotix SA
Nanobiotix SA
Balance Sheet
Nanobiotix SA
Nanobiotix SA
Currency: EUR
| Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
12
|
0
|
0
|
0
|
21
|
36
|
25
|
25
|
119
|
84
|
41
|
75
|
50
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
36
|
25
|
25
|
119
|
84
|
39
|
75
|
5
|
|
| Cash Equivalents |
1
|
1
|
1
|
12
|
0
|
0
|
0
|
21
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
44
|
|
| Short-Term Investments |
1
|
5
|
0
|
0
|
5
|
33
|
17
|
0
|
11
|
12
|
10
|
0
|
0
|
3
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
1
|
1
|
2
|
2
|
5
|
0
|
5
|
5
|
8
|
4
|
7
|
8
|
9
|
9
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
2
|
2
|
5
|
0
|
5
|
5
|
8
|
4
|
7
|
8
|
7
|
6
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
1
|
1
|
3
|
2
|
2
|
3
|
3
|
3
|
|
| Total Current Assets |
3
|
7
|
2
|
14
|
7
|
36
|
23
|
27
|
53
|
43
|
46
|
125
|
93
|
52
|
87
|
61
|
|
| PP&E Net |
1
|
1
|
1
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
9
|
8
|
8
|
7
|
6
|
6
|
|
| PP&E Gross |
1
|
1
|
1
|
0
|
0
|
1
|
2
|
0
|
3
|
3
|
9
|
8
|
8
|
7
|
6
|
6
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
2
|
2
|
4
|
5
|
7
|
8
|
9
|
11
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
4
N/A
|
8
+117%
|
3
-63%
|
14
+382%
|
7
-47%
|
37
+398%
|
26
-29%
|
30
+15%
|
57
+89%
|
46
-20%
|
56
+22%
|
134
+138%
|
102
-24%
|
60
-41%
|
94
+57%
|
67
-28%
|
|
| Liabilities | |||||||||||||||||
| Accounts Payable |
0
|
1
|
0
|
0
|
1
|
2
|
4
|
4
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
1
|
1
|
1
|
1
|
1
|
2
|
0
|
0
|
4
|
5
|
7
|
5
|
7
|
7
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
4
|
7
|
5
|
5
|
5
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
3
|
4
|
7
|
9
|
8
|
24
|
27
|
37
|
47
|
|
| Total Current Liabilities |
1
|
2
|
1
|
2
|
3
|
4
|
7
|
8
|
10
|
12
|
14
|
19
|
37
|
38
|
50
|
59
|
|
| Long-Term Debt |
0
|
0
|
0
|
1
|
1
|
2
|
4
|
4
|
4
|
17
|
41
|
41
|
36
|
49
|
46
|
46
|
|
| Other Liabilities |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
3
|
3
|
0
|
0
|
28
|
|
| Total Liabilities |
2
N/A
|
2
+17%
|
2
-2%
|
3
+67%
|
4
+28%
|
7
+58%
|
11
+60%
|
13
+20%
|
14
+4%
|
32
+136%
|
58
+82%
|
64
+9%
|
75
+18%
|
87
+16%
|
96
+10%
|
133
+39%
|
|
| Equity | |||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
3
|
10
|
15
|
5
|
12
|
22
|
37
|
57
|
81
|
109
|
156
|
187
|
230
|
284
|
317
|
380
|
|
| Additional Paid In Capital |
5
|
16
|
16
|
16
|
16
|
52
|
53
|
74
|
124
|
123
|
153
|
256
|
256
|
256
|
313
|
313
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Equity |
2
N/A
|
6
+205%
|
1
-84%
|
11
+1 051%
|
3
-70%
|
30
+853%
|
16
-49%
|
17
+11%
|
44
+152%
|
14
-68%
|
2
N/A
|
70
N/A
|
27
-62%
|
27
N/A
|
2
+93%
|
66
-3 465%
|
|
| Total Liabilities & Equity |
4
N/A
|
8
+117%
|
3
-63%
|
14
+382%
|
7
-47%
|
37
+398%
|
26
-29%
|
30
+15%
|
57
+89%
|
46
-20%
|
56
+22%
|
134
+138%
|
102
-24%
|
60
-41%
|
94
+57%
|
67
-28%
|
|
| Shares Outstanding | |||||||||||||||||
| Common Shares Outstanding |
1
|
2
|
2
|
12
|
12
|
14
|
14
|
16
|
20
|
20
|
22
|
34
|
35
|
35
|
47
|
47
|
|
Switch to:
Switch to:
See Also
Discover More
